NIH Reporter #10840314

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

NIH grant awarded to Weill Medical College of Cornell University for research on ultrasmall silica nanoparticles to induce ferroptosis and improve anti-tumor immune responses in cancer, with a focus on melanoma models.

Description

This is a NIH grant project focused on nanoparticle research for cancer therapy. The project involves studying the structural and chemical features of ultrasmall silica nanoparticles to induce ferroptosis and modulate immune responses. The project aims to optimize nanoparticle characteristics for enhanced anti-tumor effects in melanoma models. The project involves collaboration with the National Cancer Institute.

View original record